SG Americas Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$193K Sell
164,100
-152,300
-48% -$4.05M ﹤0.01% 2660
2025
Q4
$115K Sell
316,400
-160,500
-34% -$4.05M ﹤0.01% 3174
2025
Q3
$329K Hold
476,900
﹤0.01% 2414
2025
Q2
$250K Sell
476,900
-33,500
-7% -$781K ﹤0.01% 2129
2025
Q1
$409K Sell
510,400
-611,600
-55% -$16M ﹤0.01% 1944
2024
Q4
$820K Buy
1,122,000
+120,000
+12% +$3.25M ﹤0.01% 965
2024
Q3
$1.81M Buy
1,002,000
+226,600
+29% +$6.61M 0.01% 722
2024
Q2
$1.1M Buy
775,400
+327,500
+73% +$9.02M 0.01% 1267
2024
Q1
$430K Sell
447,900
-310,500
-41% -$8.62M ﹤0.01% 1503
2023
Q4
$552K Buy
758,400
+339,200
+81% +$10.3M 0.01% 1415
2023
Q3
$146K Buy
419,200
+61,300
+17% +$2.17M ﹤0.01% 2518
2023
Q2
$40K Sell
357,900
-37,200
-9% -$1.45M ﹤0.01% 2145
2023
Q1
$245K Sell
395,100
-302,800
-43% -$13.1M ﹤0.01% 2278
2022
Q4
$1.44M Sell
697,900
-248,700
-26% -$11.9M 0.02% 739
2022
Q3
$216K Sell
946,600
-1,969,900
-68% -$95.7M ﹤0.01% 2261
2022
Q2
$7.65M Sell
2,916,500
-402,000
-12% -$20.5M 0.08% 199
2022
Q1
$9.77M Buy
3,318,500
+2,480,000
+296% +$129M 0.07% 223
2021
Q4
$11.2M Buy
838,500
+32,000
+4% +$1.59M 0.06% 240
2021
Q3
$2.17M Sell
806,500
-467,400
-37% -$20.7M 0.01% 1196
2021
Q2
$1.27M Buy
1,273,900
+7,000
+0.6% +$272K 0.01% 1409
2021
Q1
$1.1M Buy
1,266,900
+945,500
+294% +$33.6M 0.01% 1469
2020
Q4
$366K Buy
321,400
+268,700
+510% +$9.86M ﹤0.01% 2223
2020
Q3
$50K Sell
52,700
-105,400
-67% -$3.7M ﹤0.01% 2520
2020
Q2
$103K Sell
158,100
-368,900
-70% -$12.5M ﹤0.01% 3351
2020
Q1
$1.91M Buy
527,000
+178,021
+51% +$6.07M 0.02% 834
2019
Q4
$148K Hold
348,979
﹤0.01% 2698
2019
Q3
$88K Sell
348,979
-632,400
-64% -$23M ﹤0.01% 2746
2019
Q2
$434K Sell
981,379
-447,950
-31% -$17.8M ﹤0.01% 1969
2019
Q1
$1.36M Buy
1,429,329
+832,765
+140% +$33.4M 0.01% 1092
2018
Q4
$1.21M Sell
596,564
-177,599
-23% -$7.37M 0.01% 1197
2018
Q3
$2.59M Sell
774,163
-1,601,975
-67% -$61.7M 0.02% 971
2018
Q2
$1.75M Buy
2,376,138
+1,613,253
+211% +$55.1M 0.02% 1009
2018
Q1
$691K Sell
762,885
-818,537
-52% -$28.1M 0.01% 1642
2017
Q4
$1.21M Sell
1,581,422
-253,170
-14% -$8.63M 0.01% 1237
2017
Q3
$3.6M Buy
1,834,592
+835,295
+84% +$26.8M 0.03% 470
2017
Q2
$1.91M Sell
999,297
-2,907,459
-74% -$91.7M 0.02% 922
2017
Q1
$3.4M Buy
3,906,756
+2,044,549
+110% +$64.5M 0.03% 589
2016
Q4
$1.47M Buy
1,862,207
+155,992
+9% +$4.76M 0.01% 1089
2016
Q3
$361K Buy
1,706,215
+611,004
+56% +$20.4M ﹤0.01% 1988
2016
Q2
$1.57M Sell
1,095,211
-142,290
-11% -$4.54M 0.01% 1001
2016
Q1
$296K Buy
1,237,501
+85,268
+7% +$2.44M ﹤0.01% 2001
2015
Q4
$336K Buy
+1,152,233
New +$36.2M ﹤0.01% 1850
2015
Q3
Sell
-1,208,833
Closed -$891K 2557
2015
Q2
$891K Buy
1,208,833
+544,286
+82% +$17.7M 0.01% 1127
2015
Q1
$1.25M Sell
664,547
-260,338
-28% -$8.28M 0.01% 1025
2014
Q4
$845K Sell
924,885
-186,242
-17% -$5.34M ﹤0.01% 1317
2014
Q3
$921K Buy
1,111,127
+336,542
+43% +$9.45M 0.01% 1186
2014
Q2
$427K Buy
+774,585
New +$22.1M ﹤0.01% 1736
2014
Q1
Sell
-1,463,057
Closed -$5.23M 2704
2013
Q4
$5.23M Sell
1,463,057
-102,344
-7% -$2.98M 0.02% 634
2013
Q3
$4.48M Sell
1,565,401
-4,080,666
-72% -$111M 0.02% 648
2013
Q2
$4.29M Buy
+5,646,067
New +$156M 0.02% 623

Other funds holding PFE

SG Americas Securities's PFE Position: Q1 2026 in Review

SG Americas Securities increased its Pfizer (PFE) stake by 76% in Q1 2026, buying an estimated $109M and bringing the position to 9,513,295 shares worth $267M. The position accounts for 0.29% of the portfolio, ranked #46.

SG Americas Securities first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $353M in Q3 2013. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SG Americas Securities held 9,513,295 shares of Pfizer worth $267M as of Q1 2026.
  • SG Americas Securities bought 4,100,329 Pfizer shares in Q1 2026, an estimated $109M.
  • Pfizer made up 0.29% of SG Americas Securities's portfolio in Q1 2026, its #46 holding.
  • SG Americas Securities first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • SG Americas Securities's Pfizer position peaked at $353M in Q3 2013.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.